Lido Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $20.4M | Buy |
45,822
+11,590
| +34% | +$5.16M | 0.08% | 143 |
|
2025
Q1 | $16.6M | Buy |
34,232
+2,626
| +8% | +$1.27M | 0.07% | 155 |
|
2024
Q4 | $12.7M | Buy |
31,606
+7,207
| +30% | +$2.9M | 0.06% | 178 |
|
2024
Q3 | $11.3M | Buy |
24,399
+335
| +1% | +$156K | 0.06% | 177 |
|
2024
Q2 | $11.3M | Buy |
24,064
+530
| +2% | +$248K | 0.06% | 154 |
|
2024
Q1 | $9.84M | Sell |
23,534
-89
| -0.4% | -$37.2K | 0.06% | 166 |
|
2023
Q4 | $9.61M | Sell |
23,623
-15,330
| -39% | -$6.24M | 0.06% | 155 |
|
2023
Q3 | $13.5M | Buy |
38,953
+21,761
| +127% | +$7.57M | 0.1% | 107 |
|
2023
Q2 | $6.05M | Sell |
17,192
-7,087
| -29% | -$2.49M | 0.04% | 185 |
|
2023
Q1 | $7.65M | Sell |
24,279
-3,953
| -14% | -$1.25M | 0.07% | 152 |
|
2022
Q4 | $8.15M | Buy |
28,232
+12,234
| +76% | +$3.53M | 0.1% | 108 |
|
2022
Q3 | $4.63M | Buy |
15,998
+11,851
| +286% | +$3.43M | 0.06% | 141 |
|
2022
Q2 | $1.17M | Buy |
4,147
+92
| +2% | +$25.9K | 0.02% | 281 |
|
2022
Q1 | $1.06M | Buy |
4,055
+712
| +21% | +$186K | 0.01% | 343 |
|
2021
Q4 | $734K | Buy |
3,343
+1,013
| +43% | +$222K | 0.01% | 438 |
|
2021
Q3 | $422K | Buy |
2,330
+295
| +14% | +$53.4K | 0.01% | 567 |
|
2021
Q2 | $410K | Buy |
2,035
+216
| +12% | +$43.5K | 0.01% | 513 |
|
2021
Q1 | $391K | Sell |
1,819
-130
| -7% | -$27.9K | 0.01% | 493 |
|
2020
Q4 | $460K | Buy |
1,949
+130
| +7% | +$30.7K | 0.01% | 444 |
|
2020
Q3 | $495K | Buy |
1,819
+211
| +13% | +$57.4K | 0.01% | 339 |
|
2020
Q2 | $467K | Buy |
1,608
+128
| +9% | +$37.2K | 0.01% | 316 |
|
2020
Q1 | $352K | Buy |
1,480
+45
| +3% | +$10.7K | 0.02% | 350 |
|
2019
Q4 | $314K | Buy |
1,435
+25
| +2% | +$5.47K | 0.01% | 431 |
|
2019
Q3 | $239K | Buy |
1,410
+15
| +1% | +$2.54K | 0.01% | 446 |
|
2019
Q2 | $255K | Buy |
1,395
+26
| +2% | +$4.75K | 0.01% | 418 |
|
2019
Q1 | $251K | Sell |
1,369
-22
| -2% | -$4.03K | 0.02% | 396 |
|
2018
Q4 | $230K | Buy |
1,391
+18
| +1% | +$2.98K | 0.02% | 345 |
|
2018
Q3 | $264K | Buy |
1,373
+49
| +4% | +$9.42K | 0.03% | 346 |
|
2018
Q2 | $225K | Sell |
1,324
-1,333
| -50% | -$227K | 0.03% | 353 |
|
2018
Q1 | $433K | Buy |
+2,657
| New | +$433K | 0.06% | 199 |
|